Health 360x brings together patients, clinicians, and researchers to enhance the health of neglected groups. Health 360x is changing clinical research through point-of-care access for patients and providers in non-academic practices that mostly serve African Americans and other patients who have historically been underrepresented in corporate and NIH clinical trials.
National Disease Research Interchange is the source of human tissues, cells and organs for scientific research. Top 250k Enrichment Emp Range Freshness 2024 - Not Found
Pulvinar Neuro is to enable and support outstanding basic and translational neuroscience research through innovative and affordable products.
Washington University School of Medicine is the medical school of Washington University in St. Louis.A leader in medical research, teaching and patient care, Washington University School of Medicine is currently ranked fourth in the nation by U.S. News & World Report. The School’s 2,100 employed and volunteer faculty physicians and clinicians -- known as Washington University Physicians -- are also medical staff members of Barnes-Jewish and St. Louis Children’s hospitals. The clinical practice group provides care to more than 430,000 children and adults at 49 clinical sites annually. Together, the institutions located on the Washington University Medical Center campus employ more than 21,000 clinicians, scientists, residents, fellows, administrators and support staff.
Rice University is a private institution that focuses on education in fields such as humanities, sciences, and engineering. It facilitates close relationships between students and faculty, allowing for personalized academic experiences. The university serves various academic disciplines and research initiatives.
Sapphiros invests in growth-stage diagnostic companies, focusing on technologies that prioritize innovation and patient-centric approaches. The company possesses a portfolio of capabilities and technologies encompassing innovative sample collection, next-generation diagnostics, computational biology, and printed electronics. These elements contribute to the global accessibility of crucial diagnostic results for consumers.
Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.
TransCode Therapeutics is an emerging RNA oncology company committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, which they believe has blockbuster potential, targets an RNA molecule that is the driver of metastatic disease across multiple tumor types and has been validated pre-clinically in its lab at MGH.
Second Sight Medical Products, Inc. is a company that specializes in the development, manufacturing, and marketing of implantable visual prosthetics aimed at providing artificial vision to blind individuals. Founded in 1998 and headquartered in Sylmar, California, the company offers innovative technologies designed to assist those with various causes of blindness, including glaucoma, diabetic retinopathy, optic nerve injuries, and retinitis pigmentosa. Its primary products include the Orion Visual Cortical Prosthesis System, which stimulates the cortex to deliver useful artificial vision, and the Argus II Retinal Prosthesis System, designed specifically for patients with outer retinal degenerations. Through its commitment to advancing medical technology, Second Sight seeks to enhance the independence and quality of life for individuals affected by blindness.
CardieX is a global health technology company that focuses on hypertension, cardiovascular disease, and other vascular health disorders.
The Indiana CTSI is dedicated to leveraging and strengthening the state’s life sciences community to achieve better health for people in Indiana.Leadership and staff at the Indiana CTSI are working to develop the best processes and resources to enable the efficient translation of scientific discoveries to patient care.Indiana CTSI programs and partnerships are designed to educate, attract and retain top research talent in the state for generations to come.
One of the nation's most respected private schools, Wake Forest University is a collegiate university recognized for its outstanding academic reputation and challenging liberal arts curriculum. Founded in 1834, Wake Forest is committed to personal education, inquiry and exploration, and service.
Medcognetics enables radiologists to control their workflow, and the offered solution improves efficiency and accuracy. Mammography patients can be prioritized by radiologists based on questionable results. They reduce breast cancer mortality by finding the disease as early as possible.
The University of North Texas Health Science Center Foundation is one of the nation’s premier academic medical centers.
Albert Einstein College of Medicine is a medical school that offers a range of academic programs, including medical degrees, graduate programs in biomedical sciences, and advanced training in clinical and research fields. Known for its emphasis on medical research and education, the college provides students with opportunities to engage in groundbreaking scientific work. Albert Einstein College of Medicine also partners with hospitals and research institutions to advance healthcare and improve patient outcomes.
Allen Institute for Brain Science is a non-profit medical research organization dedicated to understanding the complexities of bioscience. The organization encompasses three entities, the Allen Institute for Brain Science, Allen Institute for Cell Science, and Paul G. Allen Frontiers Group. Its mission is to accelerate the understanding of how the brain works in health and disease. It creates useful public resources, drive technological and analytical advances, and discover fundamental brain properties through integration of experiments using a big science, team science, and open science approach. Allen Institute for Brain Science was founded on 2003 and is based in Seattle, Washington.
John A. Burns School of Medicine is an educational institution that offers medical graduate courses and healthcare workforce programs.
WPI has a lot to offer - extraordinary students, world-renowned faculty members at the top of their fields, state-of-the-art research facilities, and a community teeming with activity. You have a lot to offer too - you're ambitious, you want to be challenged, you want to succeed, and you want to make a difference in the world. You know where you want to go; WPI can help you get there.
Arkana Laboratories offers renal pathology, neuropathology and testing, apol1, and biopharmaceutical services. It is a provider of esoteric pathologic services and a centre for pathology focused on improving care for patients. For inquiries, email, telephone numbers, and physical addresses are available on their website.
Matregenix is a MedTech company offering advanced nanofibrous materials for medical applications. MatriNova, the first application of the platform technology is a barrier membrane with characteristics for use in periodontal surgeries. Matregenix, Inc. was founded in 2018 by Sherif Soliman and is based in Irvine, California.
iQure Pharma is a global biotech company created by entrepreneurs and former pharma managers that focuses on the development of new therapeutics.
The University of Kentucky is a public, land grant university dedicated to improving people's lives through excellence in education, research and creative work, service, and health care. As Kentucky's flagship institution, the University plays a critical leadership role by promoting diversity, inclusion, economic development, and human well-being.
RAE Health is a mental health solutions company that bridges the gap between mobile health and digital therapeutics.
Second Sight Medical Products, Inc. is a company that specializes in the development, manufacturing, and marketing of implantable visual prosthetics aimed at providing artificial vision to blind individuals. Founded in 1998 and headquartered in Sylmar, California, the company offers innovative technologies designed to assist those with various causes of blindness, including glaucoma, diabetic retinopathy, optic nerve injuries, and retinitis pigmentosa. Its primary products include the Orion Visual Cortical Prosthesis System, which stimulates the cortex to deliver useful artificial vision, and the Argus II Retinal Prosthesis System, designed specifically for patients with outer retinal degenerations. Through its commitment to advancing medical technology, Second Sight seeks to enhance the independence and quality of life for individuals affected by blindness.
Lewis Katz School of Medicine is dedicated to excellence in education, research and patient care, achieved by faculty, staff and learners who represent and serve their diverse society.
Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.
We are a nationally recognized law school in the heart of University Circle, a thriving cultural neighborhood near downtown Cleveland, Ohio. Our international law, health law and intellectual property law programs are among the top in the nation. Leadership courses and real-practice experiences are infused throughout our innovative curriculum. All students begin working with real clients in their first year and participate in a semester-long full-time practice experience during their third year.
Burke Neurological Institute is the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord.
Bringing together decades of research on neurological diseases, artificial intelligence (AI), neuroscience, speech analytics, speech pathology, and mobile software platforms for health monitoring, Aural Analytics has built proprietary metrics that use speech to capture changes in neurological health. With Aural Analytics’ downloadable apps, any smartphone or tablet becomes a powerful brain health monitor. This technology augments traditional functional rating scales commonly used to measure neurological health in clinical trials with objective, interpretable, and continuous outcomes. In turn, this results in more reliable and higher resolution outcomes for evaluating the effectiveness of drugs or other interventions. Aural Analytics’ technology can reveal the incremental changes that occur as a patient progresses from one point on a functional rating scale to the next.
Cleveland Clinic is a non-profit academic medical center established in 1921 and headquartered in Cleveland, Ohio. It integrates clinical and hospital care with research and education, focusing on improving patient care, investigating medical issues, and educating healthcare providers. As a pioneer in healthcare, Cleveland Clinic became the first U.S. healthcare provider to sign the United Nations Global Compact in 2008. Its commercialization arm, Cleveland Clinic Innovations, transforms breakthrough inventions from its staff into medical products that benefit patients. This initiative fosters an inclusive environment for innovation, enabling participation from various stakeholders such as physicians, nurses, and researchers. Cleveland Clinic Innovations employs a comprehensive strategy that includes deal teams, domain experts, investment funds, and incubation facilities to support the development of new medical technologies and stimulate economic growth in Northeast Ohio and beyond.
OMRF is the Oklahoma Medical Research Foundation. We are dedicated to fighting Alzheimer’s, heart disease, lupus, MS, cancer and other devastating illnesses.
Max-IR Labs offers solutions for industrial process control, medical diagnostics, and biochemical analysis are developed by Max-IR Labs. The R&D is carried out in close collaboration with customers, with a focus on their application needs and supported by market research. Traditional techniques that interact with the analyte liquid, such as ultraviolet, electrochemical, colorimetric, and direct infrared, suffer from fouling and interferences and become unstable over time.
ETI have developed a patented, unique medical device that removes galectin-3 from human blood. The device removes both bound and free galectin-3 from the circulation, offering a new treatment option that is less invasive and has fewer side-effects than other therapies. The single-use apheresis column selectively removes Galectin-3 from the body. It contains a proprietary, highly effective capturing molecule and is built in a format that hospitals already know how to use.
Midwest Bioprocessing Center is a pioneer in glycochemical bioprocess technology.
Reliant Glycosciences is a biotechnology company focused on developing diagnostic and prognostic tools for patients with IgA nephropathy.
AVM is a clinical-stage biotech company located in Seattle WA led by Dr. Theresa Deisher, a biotech veteran with a productive history including 47 patents and 4 discoveries in clinical trials. The company's lead drug AVM0703, an innovative formulation of dexamethasone, when given at suprapharmacologic doses has a novel mechanism of action to mobilize the body's own natural supercharged immune cells. AVM0703 could be the first choice for no-option cancer, autoimmunity, and infectious disease. AVM Biotechnology has a Scientific Advisory Board including well-respected leaders in cancer and immunology.
Immunicom is redefining the limits of immunotherapy through the development of innovative, non-pharmaceutical treatment approaches for cancer, inflammatory diseases, and autoimmune diseases.
Bright Uro is an early-stage medical technology company. It is building the next generation of diagnostic devices for Urology. Utilizing advanced hardware, software, and data science can unlock new data streams and offer actionable insight for clinicians.
Albert Einstein College of Medicine is a medical school that offers a range of academic programs, including medical degrees, graduate programs in biomedical sciences, and advanced training in clinical and research fields. Known for its emphasis on medical research and education, the college provides students with opportunities to engage in groundbreaking scientific work. Albert Einstein College of Medicine also partners with hospitals and research institutions to advance healthcare and improve patient outcomes.
Talus Bio is a drug discovery biotech startup working on drug development for gene regulators. The company integrates functional proteomics, automated biology, and machine learning to target challenging cancer transcription factors. The MARMOT (Multiplexed Assays for the Rational Modulation Of Transcription Factors) platform, developed by the company, leverages AI, advanced proteomics, synthetic chemistry, and computational biology to design and analyze drugs, proteins, and genomics in a groundbreaking manner.
NovoMedix has developed novel orally available small molecules with wide therapeutic windows to treat fibrotic disorders. While these molecules have shown remarkable efficacy in animal models of fibrosis, some of them have unique properties for the treatment of cancer. These first-in-class small molecules co-target pathways that provide cardioprotective and synergistic anti-tumor effects with standard-of-care chemotherapies for the treatment of triple negative breast cancer (TNBC). There is a dose-dependent delayed and progressive cardiomyopathy often observed years after cessation of treatment of breast cancer patients anthracyclines such as doxorubicin (Adriamycin). As a result, the leading cause of death in breast cancer survivors is cardiovascular disease, often caused by the same treatments that once saved their lives. NovoMedix compounds have synergistic effects with chemotherapies on cancer cells, potentially enhancing patient response while significantly minimizing cardiotoxicity, ultimately improving long-term survival by reducing mortality due to heart failure. The goal is to initiate IND enabling studies with the lead candidate and to deliver this novel and safe therapy to TNBC patients as soon as possible.
Modality.ai is an AI-powered platform that detects health conditions using conversational AI. Through dialogue and video, Modality.AI interacts conversationally with the patient to provide health assessment anywhere, anytime. Its system analyzes multimodal data which allows continuous screening and assessing of patients’ health.
Sonavex is committed to improving outcomes for surgical patients by using cutting-edge imaging technology to provide clinicians with visualization of critical data -- directly at the point of care. The company's technology offers a proprietary technology platform that utilizes ultrasound to detect blood clots after surgery, enabling clinicians to measure critical intravascular flow metrics to detect post-operative clots directly at the point of care and improve outcomes.
Dynamoid is a 3D-interactive application. Their 10K is a platform for building VR and AI. These are effective resources for sharing, examining, working together, and having fun with data produced by actual scientific research. Their users can explore real data using their VR visualization platform, including scientific data, 3D models, and time series data.
PostEra advances small molecule programs through partnerships with biopharma while also advancing its own internal pipeline. We've raised $26M from top investors and closed $1Bn in AI partnerships, signing multi-year agreements with Amgen, Pfizer and the NIH. PostEra also launched and helped lead the world's largest open-science drug discovery effort; COVID Moonshot.
University of Arkansas for Medical Sciences is an academic health center focusing on medical education, research, and clinical programs. It offers various medical services, including specialized care in areas such as women's health, cancer treatment, orthopedics, stroke care, and trauma.
Benaroya Research Institute at Virginia Mason (BRI) is one of the few research institutes in the world dedicated to discovering causes and cures to eliminate autoimmune and immune system diseases. At BRI, their scientists aren’t focused on eliminating one or two autoimmune diseases—they’re taking on all 80. Because autoimmune diseases are connected, so is the way they’re fighting them. They're applying the breakthroughs they make against individual autoimmune diseases to make progress against them all. Through collaboration and cooperation between researchers, across clinical trials and with other institutions, they connect laboratory research to clinical trials and translate discoveries to real-life applications. As a world leader in scientific innovation, they’re leveraging this progress to eliminate autoimmune and immune system diseases in the future. Their discoveries are also having significant impact on people living with autoimmune and immune system diseases today—by improving the ability to predict disease risk, facilitate treatment, decrease progression of these diseases and make related therapies safer and more effective.
The University of Texas Health Science Center at San Antonio serves San Antonio and the 50,000 square-mile area of South Texas. It extends to campuses in the metropolitan border communities of Laredo and the Rio Grande Valley. More than 3,000 students a year train in an environment that involves more than 100 affiliated hospitals, clinics and health care facilities in South Texas. The UT Health Science Center and its Cancer Therapy & Research Center hold diversity as a core value. In this context, they are mindful of all aspects of human differences, such as socioeconomic status, race, ethnicity, language, nationality, sex, gender identity, sexual orientation, religion, geography, disability and age. At the UT Health Science Center and CTRC, inclusion is a core element for successfully achieving diversity, as they strive to create a climate that fosters belonging, respect and value for all. As an equal employment opportunity and affirmative action employer, the UT Health Science Center and CTRC exercise these core values of diversity and inclusion by promoting and ensuring equal employment opportunity for all individuals without regard to race, color, religion, sex, national origin, age, sexual orientation, disability, or veteran status.
Albert Einstein College of Medicine is a medical school that offers a range of academic programs, including medical degrees, graduate programs in biomedical sciences, and advanced training in clinical and research fields. Known for its emphasis on medical research and education, the college provides students with opportunities to engage in groundbreaking scientific work. Albert Einstein College of Medicine also partners with hospitals and research institutions to advance healthcare and improve patient outcomes.
Simulations Plus is a developer of Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) and Physiologically-Based Pharmacokinetic (PBPK) modeling and simulation software for the pharmaceutical and biotechnology, generics, chemical, cosmetic, and food ingredient industries today. Our software allows pharmaceutical scientists to predict certain key potential endpoints and dynamics, in silico, thereby reducing research & development costs and helping clients make better projects decisions... sooner. Founded in 1996, Simulations Plus employs over 60 employees and is publicly-traded on the NASDAQ stock exchange (ticker symbol = SLP).Our headquarters are based in Lancaster, California, with our pharmacometrics consulting team located in Buffalo, New York. Trusted distributors handle sales and scientific support in Asian territories. 19 of the top 20 pharmaceutical companies, plus numerous mid- and small-sized companies and all major regulatory agencies, license our modeling & simulation technology.
Dascena develops machine learning algorithms to enable early disease intervention and improve care outcomes for patients. Dascena utilizes healthcare patient data to help detect disease, improve the delivery of care, and save lives. Dascena solves unmet healthcare needs in applications such as clinical decision support, point of care diagnostics, and biopharma companion diagnostics.
Enspectra Health, based in Mountain View, California, has developed the world’s first hand-held multiphoton imager for human use and is delivering imaging systems to researchers investigating the structure and function of muscle, tendon, cartilage, skin, and other tissues.
Melax Tech creates biomedical NLP technology to help healthcare and life science organizations solve real-world problems with NLP. Melax Tech offers a variety of CLAMP-based software, both on-premises and in the cloud. Meric is a text annotation product for medical and life science projects that is self-service and pay-as-you-go. LANN, a literature annotation tool, assists researchers in the pharmaceutical and related industries in locating references to diseases, medications, adverse drug reactions, and usage patterns. VITAL is chart review software that improves billing and coding accuracy, among other things.
Arc Bio is a bioscience company that provides microbial detection by developing novel metagenomic next-generation sequencing solutions. Their platform enables a sample-to-result integrated workflow that takes the user from a primary sample to quantitative results. Arc Bio revolutionizes microbial detection with turnkey metagenomic next-generation sequencing workflows and software solutions for fast, precise, and cost-effective analyses.
Eastern Michigan University in Ypsilanti, Michigan, offers comprehensive academic and professional programs of study, including unique majors and those that are nationally recognized. Eastern Michigan’s undergraduate programs encompass creative, scholastic and career-oriented fields. Some examples of Eastern Michigan’s diverse majors include: * Art History * Aviation Flight Technology * Creative Writing * Japanese Language and Culture * Public Relations * Social Work Eastern Michigan also offers such unique majors and graduate degrees as: * Arts Management * Children’s Literature and Theatre * Music Therapy * Orthotics and Prosthetics Dual bachelor’s and master’s degrees are also available in such fields as Occupational Therapy. Eastern Michigan’s academics are also of high quality, with some of its programs, like Special Education and Forensics, ranking well nationally. College life at Eastern Michigan is comprehensive, including more than 200 student organizations and clubs. Ypsilanti is also a short distance from both the lively college town of Ann Arbor as well as the concerts and attractions of Detroit. First-time freshmen will need to submit an application with transcripts or a GED score and ACT or SAT scores. A minimum GPA of 2.0 is generally required. Financial aid awards include need-based programs like federal grants and loans. Eastern Michigan also offers more than 30 scholarships. Each scholarship has different eligibility requirements, which could include everything from grades and test scores to financial need to community service involvement.
The Information Technologies & Services Department (ITS) provides comprehensive IT infrastructure, management, service, and support for the Weill Cornell Medical College community. With its wide range of expertise in new and emerging technologies, ITS plays a vital role in advancing the institution’s mission in education, biomedical research, and patient care. With over 300 employees, ITS supports more than 10,000 computer users, over 1,000 servers, and numerous clinical, research, and administrative software applications. Their staff's expertise and service offerings spans all areas of technology, from ensuring institutional security standards to creation of high speed networking, from developing websites to assisting with hardware purchasing. ITS also creates innovative computer systems and applications for specific clinical and research projects, including cutting-edge work in genetics and structural biology. As a recipient of major grants for its many initiatives at Weill Cornell Medical College, ITS is a creative leader in the multidisciplinary field of medicine and technology.
NYU Langone Medical Center, a world-class, patient-centered, integrated, academic medical center, is one of the nation's premier centers for excellence in clinical care, biomedical research and medical education. Located in the heart of Manhattan, NYU Langone is composed of four hospitals – Tisch Hospital, its flagship acute care facility; Rusk Rehabilitation; the Hospital for Joint Diseases, one of only five hospitals in the nation dedicated to orthopaedics and rheumatology; and Hassenfeld Children’s Hospital, a comprehensive pediatric hospital supporting a full array of children's health services across the medical center – plus the NYU School of Medicine, which since 1841 has trained thousands of physicians and scientists who have helped to shape the course of medical history. The medical center's tri-fold mission to serve, teach and discover is achieved 365 days a year through the seamless integration of a culture devoted to excellence in patient care, education and research.
Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making. It revolutionizes the way genetic diagnoses and discoveries are made. The company’s suite of diagnostic and discovery tools enable physicians, pharma, and researchers to quickly and accurately identify disease-causing variants from genomic-sequencing datasets. It was founded in 2014 and is headquartered in Ann Arbor, Michigan.
Epicore Biosystems develops a proprietary wearable microfluidic platform that is ‘skin-like’ and capable of analyzing small droplets of sweat for proteomics, inflammatory markers, hydration, and health biomarkers to enable personalized management of health, performance ,and nutrition. Epicore's wearable sensing technology is based on over two decades of microfluidics and soft materials research by Prof. John Rogers and Dr. Roozbeh Ghaffari at Northwestern University's Querrey-Simpson Institute for Bioelectronics.
Meridian Bioscience is an integrated life science company. The Company is engaged in developing, manufacturing, selling, and distributing clinical diagnostic test kits, for certain gastrointestinal, viral, respiratory, and parasitic infectious diseases; the manufacture and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/ quantitative polymerase chain reaction (qPCR) reagents, nucleotides, competent cells and bioresearch reagents used by researchers and other diagnostic manufacturers, and the contract development and manufacture of proteins and other biologicals under cyclic guanosine monophosphate (cGMP) conditions for use by biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines. The Company operates in three segments: U.S. Diagnostics, European Diagnostics, and Life Science.
Novoron Bioscience develops new therapeutic approaches to address neurological damage or disease in the central nervous system (CNS). Our novel LRP-focused science enables hope for treatment of conditions for which no current therapies exist. We’re advancing multiple biological therapeutics that treat pathologies of the CNS, including tauopathies (Alzheimer’s, CTE, TBI, etc.), acute spinal cord injury (orphan drug indication), and demyelinating conditions (multiple sclerosis, NMO, etc.).
Subtle Medical is a healthcare technology company that provides AI-powered medical imaging. Its products, SubtlePET and SubtleMR, are FDA Cleared and CE Marked AI product that enhances images in PET and MR exams aimed for faster & safer workflow. The company's SubtleGAD technology is also awarded by RSNA and a $1.6M NIH SBIR Grant to facilitate the adoption using AI to make imaging exams safer. They provide a vendor-agnostic AI infrastructure powering its products and providing service and analytics to clinical imaging providers. Subtle Medical's goal is to improve the quality, value, and accessibility of medical imaging by significantly reducing cost, imaging time, and radiation dose.
Midwest Bioprocessing Center is a pioneer in glycochemical bioprocess technology.
FAU - College of Engineering and Computer Science is an academic college of Florida Atlantic University. It encompasses three academic departments and nine technical disciplines and offers 20 degree programs. The courses offered are presented on-campus, off-campus, and through distance learning in bioengineering, civil engineering, computer engineering, computer science, electrical engineering, geomatics engineering, mechanical engineering, and ocean engineering. FAU - College of Engineering and Computer Science was founded in 1965.
Phase provides 3D-printing medical devices for microfluidics. Phase’s proprietary platform enables PDMS (Sylgard 184) to be 3D printed at a scale and resolution that was previously unattainable.
Penn Medicine is the medical school of the University of Pennsylvania that provides medical research and education services. Today, a Penn physician, scientist, nurse, technician or social worker will find another way to heal or help, unlock medical science that can give the gift of more time and change the course of human life.
Bleep provides best new CPAP solution on the market. Not sleeping sucks. Not sleeping and spending a fortune on CPAP devices that leak, fall off or leave marks on your face sucks even worse. That’s why they invented the DreamPort Sleep Solution – the world’s first-ever mask less CPAP device. The result is the smallest, lightest, most ergonomically accommodating CPAP solution on the market – a device that fits comfortably and doesn’t restrict your movement – enabling patients to get a better night’s sleep. Their goal is simple – to make the best bleeping CPAP products on the planet. They won’t stop until every sleep apnea patient is sleeping like a baby.
Delpor, Inc. engages in developing and acquiring drug delivery technologies that enable the sustained or pattern specific release of proteins, peptides, and small molecules through a small non-mechanical subcutaneous implant. Its technologies include Prozor, which is used for the delivery of antipsychotics and other small molecule drugs from a non-mechanical implantable drug delivery device; NANOPOR, a non-mechanical implantable drug delivery device in which sustained release is provided by membrane architecture; and Delos PUMP, a self-contained and electro-osmotically driven implantable drug delivery device to deliver drugs in predetermined patterns. The company was incorporated in 2009 and is based in San Francisco, California.
Inflammatix develops novel molecular diagnostics for acute infections and sepsis that work by 'reading' the immune system. It is a molecular diagnostics company developing rapid tests that read the immune system to resolve major clinical and public health challenges. They are initially focused on developing tests for acute bacterial and viral infections, and sepsis based on patent-pending biomarkers exclusively licensed from Stanford University.
4E Therapeutics is developing an innovative therapy for chronic neuropathic pain and is also at the forefront of discovering and developing compounds to treat migraine and acute pain. Neuropathic pain is a serious unmet medical need. They make an effort to regulate the activity of pain-sensing neurons in the peripheral nervous system.
Arkansas Children's Research Institute is a not-for-profit corporation owned by Arkansas Children's, Inc.
Anavasi Diagnostics is a medical technology company that focuses on the development of molecular diagnostic testing.
Tuskegee University in Tuskegee, Alabama, is a historically black university (HBCU) of academic excellence and innovation. Tuskegee distinguishes itself by offering programs of study not found at any other historically black university. Tuskegee also graduates a majority of the nation’s successful African American scientists and engineers. Tuskegee’s programs of study are offered through several distinctive colleges. These include the colleges of: * Architecture and Construction Science * Arts and Sciences * Business and Information Science * Education Tuskegee is also one of the only African American institutions that offers a degree in veterinary science. Consequently, the majority of the world’s African American veterinarians graduated from Tuskegee. Tuskegee also produces many of the nation’s aerospace, chemical and electrical engineers. While Tuskegee is historically black, the school welcomes students of all backgrounds. Required admissions materials include an application, which applicants can download from the website, transcripts and ACT or SAT scores. Tuskegee awards several competitive, academic scholarships. Tuskegee awards these to students with an exceptional GPA and test scores. Tuskegee students may also apply for federal financial aid. Federal aid is given on the basis of financial need and includes grants and loans. To apply for federal aid, applicants must submit a FAFSA.
Michigan State University is an educational institution that offers undergraduate, graduate, and research programs in the fields of business, humanities, science and technology, and public affairs. The schools and colleges of the university include College of Agriculture and Natural Resources, College of Arts and Letters, Eli Broad College of Business and The Eli Broad Graduate School of Management, College of Education, College of Human Ecology, College of Engineering, College of Human Medicine, College of Nursing, College of Osteopathic Medicine, College of Social Science, College of Veterinary Medicine, and College of Natural Science. Michigan State University was founded in 1855 and is based in East Lansing, Michigan.
Mustang Bio is a clinical-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel cancer immunotherapy products designed to utilize the power of the patient's own immune system to eliminate cancer cells. The products under development are - CD123, CD20, and CS1.
InterveXion is a privately-held clinical-stage biopharmaceutical company developing novel product candidates for the treatment of addiction disorders. Their lead clinical asset is IXT-m200, a monoclonal antibody directed against methamphetamine, which acts by re-partitioning methamphetamine away from its sites of action in the CNS. IXT-m200 has received US FDA Fast Track Designation, and is being studied in an ongoing Phase 2 proof-of-concept study (STAMPOUT; NCT03336866). They are also developing a novel vaccine (IXT-v100) against methamphetamine, which is in Preclinical Development.
The Los Angeles Biomedical Research Institute (LA BioMed) is a 501(c)3 independent non-profit biomedical research organization that was founded in 1952. The Institute has over more than 120 principal investigators and 400 researchers in total — MD’s, MD/PhD’s, and PhD’s — working on over 1,000 research studies. They are academically affiliated with the David Geffen School of Medicine at UCLA and work in partnership with the Harbor-UCLA Medical Center. Their research is funded by many sources including: grants from the NIH and other government entities, Industry and teaching contracts and royalties, as well as private donors and other non-profit foundations.
Albert Einstein College of Medicine is a medical school that offers a range of academic programs, including medical degrees, graduate programs in biomedical sciences, and advanced training in clinical and research fields. Known for its emphasis on medical research and education, the college provides students with opportunities to engage in groundbreaking scientific work. Albert Einstein College of Medicine also partners with hospitals and research institutions to advance healthcare and improve patient outcomes.
A biomarker test to diagnose a common and life-threatening bowel disease in preterm infants. It offers more accurate results than current options and allows earlier medical intervention.
SeLux Diagnostics is a developer of the next-generation phenotyping platform that provides personalized antimicrobial therapies to patients. The company is revolutionizing patient care by expediting the selection of personalized antimicrobial therapy for all infectious disease patients. This advancement will save lives, reduce hospital stays, and address the escalating antibiotic resistance epidemic by minimizing the overuse of broad-spectrum agents.
Drexel University, founded in 1891 and located in Philadelphia, is a prominent global research institution with approximately 26,000 students, ranking among the top 100 universities in the United States. Recognized for its leadership in experiential learning, particularly through its Co-op program, Drexel is also noted for its pioneering work in academic technology and translational research. The university operates multiple campuses in Philadelphia and engages in international research partnerships, enhancing its global presence. Drexel is one of the largest private universities in the nation and a major economic driver in the Philadelphia region, where it ranks among the top employers. The university is committed to civic engagement, integrating community partnerships into its academic and service initiatives. Additionally, Drexel’s endowment fund supports scholarships and various university operations, with investment strategies focused on diverse asset classes, ensuring financial stability and academic excellence.
Florida State University (FSU) is a distinguished institution located in the heart of Florida's capital, known for its rich heritage and commitment to academic excellence. As the oldest continuous site of higher education in Florida, FSU offers a diverse range of programs through its 16 colleges, encompassing over 275 undergraduate, graduate, doctoral, professional, and specialist degrees. The university is recognized for its strong emphasis on the arts and humanities, as well as its leadership in the sciences, particularly through research opportunities at the National High Magnetic Field Laboratory, the only national lab in the state. Each year, FSU awards more than 2,000 graduate and professional degrees, contributing to a global network of over 300,000 alumni. With nationally-ranked academics and championship athletics, FSU provides a vibrant and supportive environment for students, fostering their potential to achieve extraordinary outcomes.
Diseases of the neuromuscular junction have profound health effects including paralysis, breathing and swallowing difficulties. Amplo Biotechnology plans to develop multiple, potentially curative, Adeno-Associated Viral (AAV) therapies for the neuromuscular junction with an initial focus on congenital myasthenic syndromes. Amplo’s lead program, AAV-Dok7, was developed by Professor Yuji Yamanashi's group of the Institute of Medical Science at the University of Tokyo, and is applicable to multiple rare, severe diseases.
Benten Technologies is a social impact company focused on democratizing healthcare. We have obtain approximately $9M in non-dilutive funding to build a pipeline of digital therapeutics to democraticratize healthcare services.
Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.
Partillion Bioscience is an early-stage life science company developing a functional single-cell analysis platform to analyze and sort single cells based on secreted proteins. The platform allows the rapid compartmentalization and analysis of millions of single cells to probe biological functions.
Autonomous Healthcare is a medical technology company pioneering the use of automation in clinical care workflows
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. They utilize ambient light-sensitive molecules to re-sensitize the retina toward a low light level. Its light-assisted gene therapy is highly targeted to geographic atrophies without perturbing the intact retina circuitry.
Vibrato Medical is creating a noninvasive treatment for Critical Limb Ischemia and Peripheral Arterial Disease in order to increase tissue perfusion, alleviate symptoms, and save limbs. Based on decades of study and the most recent advances in ultrasound technology, our gadget is the first wearable therapeutic ultrasound designed to stimulate vasodilation and vessel development.
Thermogenesis is a healthcare company that focuses on the development and commercialization of automated technologies for cell-based therapeutics and bioprocessing. It is a supplier of enabling technologies for the processing and storage of stem cells and biological tissues.
Arkansas Children's Research Institute is a not-for-profit corporation owned by Arkansas Children's, Inc.
On average, we spend a third of our lives in bed. Our self-positioning bed; the Korus™, combined with our AI-driven software, is designed to provide precise sleep therapies improving lifestyle and medical care that benefits sleep wellness and faster recovery at home.
Amydis is a privately-held pharmaceutical company focused on developing innovative chemistry to detect diseases that involve the presence of amyloid proteins. Our mission is to develop a universal, non-invasive diagnostic that is faster, more accessible, and more affordable than current tests for diseases with unmet clinical and medical needs. Amydis has a platform of novel compounds that fluoresces when bound to amyloid proteins, thus enabling diagnosis of such diseases. The Company’s most advanced program is targeting the detection of early stage Alzheimer’s disease, a well-known amyloid disease. Other potential development programs include the detection of Parkinson’s disease, Creutzfeldt-Jakob disease (mad cow disease), Pre-eclampsia, TTR Amyloidosis, and Cerebral Amyloid Angiopathy, all of which are associated with the presence of amyloid protein. Amydis offers you and your loved ones the ability to know whether you are at risk for Alzheimer’s or other amyloid-associated diseases. Knowing will allow you and your healthcare professional to make the right decisions.
Omnix Medical is dedicated to the development and commercialization of highly effective antibiotic agents against resistant pathogenic bacterial strains. Omnix is addressing an enormous and rapidly growing threat to public health, represented by millions worldwide, who suffer from infections associated with resistant bacteria. Omnix’s technology will tilt the odds in the battle against resistant bacteria and improve the lives of many people worldwide.
Phrase Health help hospitals monitor and analyze the information they provide to doctors and nurses at the point of care.
ImmunoBrain Checkpoint is a biopharmaceutical company focused on developing a pipeline of novel disease-modifying immunotherapies for neurological disorders by targeting immune checkpoint pathways. IBC’s novel approach for treatment of neurodegeneration is based on years of innovative, cutting edge scientific discoveries made by Prof. Michal Schwartz (Weizmann Institute of Science, Israel).
Eclipse Regenesis is a development-stage medical device company focused on harnessing the body’s own tissue regeneration capabilities to treat important diseases. Its flagship product, the Eclipse XL1 System™, utilizes distraction enterogenesis in a treatment designed to mechanically stimulate the body to produce new, fully-functional intestinal to address Short Bowel Syndrome (SBS). With the support of more than 15 years of scientific research and the participation of SBS thought leaders from around the world, the Eclipse Regenesis team is passionate about pioneering a restorative therapy for a disease state that has no cure today. The Eclipse XL1 System is an investigational device and is not currently available commercially in any region.
Hesperos, Inc. is a leader in efforts to characterize an individual's biology with Human-on-a-Chip microfluidic systems. Founders Michael L. Shuler and James J. Hickman have been at the forefront of every major scientific discovery in this realm, from individual organ-on-a-chip constructs to fully functional, interconnected multi-organ systems. With a mission to revolutionize toxicology testing as well as efficacy evaluation for drug discovery, the company has created pumpless platforms with serum-free cellular mediums that allow multi-organ system communication and integrated computational PKPD modeling of live physiological responses utilizing functional readouts from neurons, cardiac, muscle, barrier tissues and neuromuscular junctions as well as responses from liver, pancreas and barrier tissues.
CareKinesis, Inc. provides state-of-the-art medication management through a combination of technology, science and services that reduces costs, improves the quality of care and decreases the risks associated with ineffective medication plans.